We often profile customers who are working on particularly interesting genetic research projects on The Genetic Link, in the hope that it will benefit other customers. Dr. Nasir Ali Afsar MBBs, M.Phil, Ph.D. from the College of Medicine at Alfaisal University in Saudi Arabia is one such researcher with a project we thought was worth sharing.
DNA Genotek's Sample Collection Blog
Through their participation in the IMPACT research study (Individualized Medicine: Pharmacogenetic Assessment & Clinical Treatment), practitioners in Canada are now able to offer certain patients a saliva-based genetic test to predict which psychiatric medications work best for them. The tests enable physicians to use a patient’s genetic makeup to help predict which medications are safe to prescribe, and which ones may be ineffective or cause side effects. The tests are aimed at minimizing trial-and-error prescribing/dosing and are expected to reduce associated health care costs. The pharmacogenetic tests, currently offered to Centre for Addiction and Mental Health (CAMH) clients and registered patients at the Thornhill Medical Centre, use DNA from saliva collected with Oragene for the purposes of the research. Plans are being made to incorporate several other Ontario healthcare facilities into the IMPACT study. This study is making the promise of personalized medicine a reality.
This morning, Clinical Reference Laboratory (CRL) announced that it has completed validation testing of DNA Genotek's Oragene/saliva collection kits and will adopt Oragene for use with its molecular diagnostic services.